{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:08:28Z","timestamp":1792782508908,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T00:00:00Z","timestamp":1766275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T00:00:00Z","timestamp":1766275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013589","name":"Research England","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013589","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000901","name":"Juvenile Diabetes Research Foundation International","doi-asserted-by":"publisher","award":["3-SRA-2023-1311-S-B"],"award-info":[{"award-number":["3-SRA-2023-1311-S-B"]}],"id":[{"id":"10.13039\/100000901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","award":["21\/0006353"],"award-info":[{"award-number":["21\/0006353"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008664","name":"Juvenile Diabetes Research Foundation United Kingdom","doi-asserted-by":"publisher","award":["1-SGA-2024-0003"],"award-info":[{"award-number":["1-SGA-2024-0003"]}],"id":[{"id":"10.13039\/100008664","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Steve Morgan Foundation Grand Challenge","award":["22\/0006504"],"award-info":[{"award-number":["22\/0006504"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims\/hypothesis<\/jats:title>\n                    <jats:p>Culture-expanded mesenchymal stromal cells (MSCs) reduce immune cell activation and improve islet functional survival. However, little is known about human pancreatic MSCs (pMSCs) in health or how they are altered in type 1 diabetes. Here, we determined the number, density and islet-protective phenotype of pMSCs in situ in individuals with and without type 1 diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Multiplex immunohistochemistry was used to identify pMSCs (CD90\n                      <jats:sup>+<\/jats:sup>\n                      \/CD105\n                      <jats:sup>+<\/jats:sup>\n                      \/CD73\n                      <jats:sup>+<\/jats:sup>\n                      \/CD31\n                      <jats:sup>\u2212<\/jats:sup>\n                      \/CD45\n                      <jats:sup>\u2212<\/jats:sup>\n                      \/CD34\n                      <jats:sup>\u2212<\/jats:sup>\n                      ) in human pancreas sections from 38 donors (Network for Pancreatic Organ Donors with Diabetes and Exeter Archival Diabetes Biobank). Donors were categorised as either &lt;13 years at type 1 diabetes diagnosis (\n                      <jats:italic>n<\/jats:italic>\n                      =8) or \u226513 years at type 1 diabetes diagnosis (\n                      <jats:italic>n<\/jats:italic>\n                      =11) or were sex-matched individuals of similar age without diabetes. Consecutive sections were immunostained with antisera against insulin, glucagon and the established islet-protective and immunomodulatory factors annexin A1 (ANXA1) and indoleamine 2,3-dioxygenase 1. Whole-slide scans were acquired and pMSCs either inside or at the periphery (within 10 \u00b5m) of islets were quantified on an individual-islet basis. We identified 53,375 pMSCs and performed an analysis of 26,376 individual islets. Culture-expanded MSCs were exposed to cytokines and viability and proliferation were assessed by flow cytometry.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      pMSCs were identified in situ in the human pancreas where they wrap around the islet periphery in an expected spindle-like morphology. ANXA1 was expressed by 33.2% of pMSCs and was expressed constitutively among individuals with or without diabetes. The density of both intraislet pMSCs and pMSCs within 10 \u00b5m of the islet periphery was increased for insulin-containing islets in individuals with type 1 diabetes compared with individuals without diabetes (\n                      <jats:italic>p<\/jats:italic>\n                      &lt;0.001). pMSC density within 10 \u00b5m of the islet periphery was preferentially increased in individuals \u226513 years at type 1 diabetes diagnosis compared with individuals &lt;13 years at type 1 diabetes diagnosis (\n                      <jats:italic>p<\/jats:italic>\n                      &lt;0.001). pMSC density was reduced around insulin-deficient islets compared with insulin-containing islets in individuals with diabetes (\n                      <jats:italic>p<\/jats:italic>\n                      &lt;0.001), consistent with an islet-protective role for pMSCs. Exposure of culture-expanded MSCs to an aggressive cytokine combination led to increased cell death and reduced proliferation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions\/interpretation<\/jats:title>\n                    <jats:p>pMSCs express ANXA1 constitutively, suggesting an islet-protective role in health. The density of pMSCs was increased around insulin-containing islets and lost around insulin-deficient islets in individuals with type 1 diabetes which aligns with this hypothesis. pMSC density at the periphery of insulin-containing islets was preferentially higher in individuals with later-onset type 1 diabetes, correlating with a less intense immune cell infiltration. The reduced ability of pMSCs to survive in the more intense proinflammatory environment around islets in younger-onset type 1 diabetes may contribute to the rapid rate of beta cell loss in these individuals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s00125-025-06634-w","type":"journal-article","created":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T06:27:36Z","timestamp":1766298456000},"page":"966-986","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Characterisation of human pancreatic mesenchymal stromal cells in type 1 diabetes"],"prefix":"10.1007","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8940-1094","authenticated-orcid":false,"given":"Rebecca E.","family":"Dewhurst-Trigg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5884-386X","authenticated-orcid":false,"given":"Jocelyn","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1537-8113","authenticated-orcid":false,"given":"Noel G.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8675-2822","authenticated-orcid":false,"given":"Martin","family":"Eichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1160-6062","authenticated-orcid":false,"given":"Sarah J.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4314-6109","authenticated-orcid":false,"given":"Chloe L.","family":"Rackham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,21]]},"reference":[{"issue":"2","key":"6634_CR1","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2337\/db14-0656","volume":"64","author":"PO Carlsson","year":"2015","unstructured":"Carlsson PO, Schwarcz E, Korsgren O, Le Blanc K (2015) Preserved \u03b2-cell function in type 1 diabetes by mesenchymal stromal cells. Diabetes 64(2):587\u2013592. https:\/\/doi.org\/10.2337\/db14-0656","journal-title":"Diabetes"},{"issue":"8","key":"6634_CR2","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00125-023-05934-3","volume":"66","author":"PO Carlsson","year":"2023","unstructured":"Carlsson PO, Espes D, Sisay S, Davies LC, Smith CIE, Svahn MG (2023) Umbilical cord-derived mesenchymal stromal cells preserve endogenous insulin production in type 1 diabetes: a Phase I\/II randomised double-blind placebo-controlled trial. Diabetologia 66(8):1431\u20131441. https:\/\/doi.org\/10.1007\/s00125-023-05934-3","journal-title":"Diabetologia"},{"key":"6634_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.metabol.2018.10.005","volume":"90","author":"G P\u00e4th","year":"2019","unstructured":"P\u00e4th G, Perakakis N, Mantzoros CS, Seufert J (2019) Stem cells in the treatment of diabetes mellitus - focus on mesenchymal stem cells. Metabolism 90:1\u201315. https:\/\/doi.org\/10.1016\/j.metabol.2018.10.005","journal-title":"Metabolism"},{"issue":"7","key":"6634_CR4","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.numecd.2017.02.004","volume":"27","author":"V Sordi","year":"2017","unstructured":"Sordi V, Pellegrini S, Krampera M et al (2017) Stem cells to restore insulin production and cure diabetes. Nutr Metab Cardiovasc Dis 27(7):583\u2013600. https:\/\/doi.org\/10.1016\/j.numecd.2017.02.004","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"9","key":"6634_CR5","doi-asserted-by":"publisher","first-page":"4542","DOI":"10.4049\/jimmunol.1202710","volume":"190","author":"JL Reading","year":"2013","unstructured":"Reading JL, Yang JH, Sabbah S et al (2013) Clinical-grade multipotent adult progenitor cells durably control pathogenic T cell responses in human models of transplantation and autoimmunity. J Immunol 190(9):4542\u20134552. https:\/\/doi.org\/10.4049\/jimmunol.1202710","journal-title":"J Immunol"},{"issue":"2","key":"6634_CR6","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.imlet.2015.05.004","volume":"168","author":"K Le Blanc","year":"2015","unstructured":"Le Blanc K, Davies LC (2015) Mesenchymal stromal cells and the innate immune response. Immunol Lett 168(2):140\u2013146. https:\/\/doi.org\/10.1016\/j.imlet.2015.05.004","journal-title":"Immunol Lett"},{"issue":"5","key":"6634_CR7","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/stem.3143","volume":"38","author":"TT Cooper","year":"2020","unstructured":"Cooper TT, Sherman SE, Bell GI et al (2020) Characterization of a Vimentin(high) \/Nestin(high) proteome and tissue regenerative secretome generated by human pancreas-derived mesenchymal stromal cells. Stem Cells 38(5):666\u2013682. https:\/\/doi.org\/10.1002\/stem.3143","journal-title":"Stem Cells"},{"issue":"5","key":"6634_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1089\/scd.2020.0206","volume":"30","author":"TT Cooper","year":"2021","unstructured":"Cooper TT, Sherman SE, Bell GI et al (2021) Ultrafiltration and injection of islet regenerative stimuli secreted by pancreatic mesenchymal stromal cells. Stem Cells Dev 30(5):247\u2013264. https:\/\/doi.org\/10.1089\/scd.2020.0206","journal-title":"Stem Cells Dev"},{"issue":"1","key":"6634_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1089\/scd.2010.0583","volume":"21","author":"GI Bell","year":"2012","unstructured":"Bell GI, Broughton HC, Levac KD, Allan DA, Xenocostas A, Hess DA (2012) Transplanted human bone marrow progenitor subtypes stimulate endogenous islet regeneration and revascularization. Stem Cells Dev 21(1):97\u2013109. https:\/\/doi.org\/10.1089\/scd.2010.0583","journal-title":"Stem Cells Dev"},{"issue":"7","key":"6634_CR10","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.2337\/dc12-0063","volume":"35","author":"FB Barton","year":"2012","unstructured":"Barton FB, Rickels MR, Alejandro R et al (2012) Improvement in outcomes of clinical islet transplantation: 1999\u20132010. Diabetes Care 35(7):1436\u20131445. https:\/\/doi.org\/10.2337\/dc12-0063","journal-title":"Diabetes Care"},{"issue":"7","key":"6634_CR11","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s00125-009-1374-z","volume":"52","author":"AM Madec","year":"2009","unstructured":"Madec AM, Mallone R, Afonso G et al (2009) Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells. Diabetologia 52(7):1391\u20131399. https:\/\/doi.org\/10.1007\/s00125-009-1374-z","journal-title":"Diabetologia"},{"issue":"5","key":"6634_CR12","doi-asserted-by":"publisher","first-page":"e38189","DOI":"10.1371\/journal.pone.0038189","volume":"7","author":"TY Yeung","year":"2012","unstructured":"Yeung TY, Seeberger KL, Kin T et al (2012) Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines. PLoS One 7(5):e38189. https:\/\/doi.org\/10.1371\/journal.pone.0038189","journal-title":"PLoS One"},{"issue":"1","key":"6634_CR13","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s00125-016-4120-3","volume":"60","author":"JP Cunha","year":"2017","unstructured":"Cunha JP, Leuckx G, Sterkendries P et al (2017) Human multipotent adult progenitor cells enhance islet function and revascularisation when co-transplanted as a composite pellet in a mouse model of diabetes. Diabetologia 60(1):134\u2013142. https:\/\/doi.org\/10.1007\/s00125-016-4120-3","journal-title":"Diabetologia"},{"issue":"2","key":"6634_CR14","doi-asserted-by":"publisher","first-page":"993","DOI":"10.4049\/jimmunol.0900803","volume":"183","author":"P Fiorina","year":"2009","unstructured":"Fiorina P, Jurewicz M, Augello A et al (2009) Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J Immunol 183(2):993\u20131004. https:\/\/doi.org\/10.4049\/jimmunol.0900803","journal-title":"J Immunol"},{"issue":"7","key":"6634_CR15","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s00125-022-05708-3","volume":"65","author":"E Kawada-Horitani","year":"2022","unstructured":"Kawada-Horitani E, Kita S, Okita T et al (2022) Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade. Diabetologia 65(7):1185\u20131197. https:\/\/doi.org\/10.1007\/s00125-022-05708-3","journal-title":"Diabetologia"},{"issue":"8","key":"6634_CR16","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/stem.1132","volume":"30","author":"F Ezquer","year":"2012","unstructured":"Ezquer F, Ezquer M, Contador D, Ricca M, Simon V, Conget P (2012) The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1\/Th2 balance and to modify the pancreatic microenvironment. Stem Cells 30(8):1664\u20131674. https:\/\/doi.org\/10.1002\/stem.1132","journal-title":"Stem Cells"},{"issue":"2","key":"6634_CR17","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00125-015-3808-0","volume":"59","author":"E Favaro","year":"2016","unstructured":"Favaro E, Carpanetto A, Caorsi C et al (2016) Human mesenchymal stem cells and derived extracellular vesicles induce regulatory dendritic cells in type 1 diabetic patients. Diabetologia 59(2):325\u2013333. https:\/\/doi.org\/10.1007\/s00125-015-3808-0","journal-title":"Diabetologia"},{"issue":"2","key":"6634_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00441-016-2499-2","volume":"368","author":"J Xv","year":"2017","unstructured":"Xv J, Ming Q, Wang X et al (2017) Mesenchymal stem cells moderate immune response of type 1 diabetes. Cell Tissue Res 368(2):239\u2013248. https:\/\/doi.org\/10.1007\/s00441-016-2499-2","journal-title":"Cell Tissue Res"},{"issue":"1","key":"6634_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/stem.259","volume":"28","author":"V Sordi","year":"2010","unstructured":"Sordi V, Melzi R, Mercalli A et al (2010) Mesenchymal cells appearing in pancreatic tissue culture are bone marrow-derived stem cells with the capacity to improve transplanted islet function. Stem Cells 28(1):140\u2013151. https:\/\/doi.org\/10.1002\/stem.259","journal-title":"Stem Cells"},{"issue":"12","key":"6634_CR20","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.jcyt.2020.07.010","volume":"22","author":"KL Thirlwell","year":"2020","unstructured":"Thirlwell KL, Colligan D, Mountford JC et al (2020) Pancreas-derived mesenchymal stromal cells share immune response-modulating and angiogenic potential with bone marrow mesenchymal stromal cells and can be grown to therapeutic scale under Good Manufacturing Practice conditions. Cytotherapy 22(12):762\u2013771. https:\/\/doi.org\/10.1016\/j.jcyt.2020.07.010","journal-title":"Cytotherapy"},{"issue":"1","key":"6634_CR21","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s13287-019-1435-2","volume":"10","author":"B Khiatah","year":"2019","unstructured":"Khiatah B, Qi M, Du W et al (2019) Intra-pancreatic tissue-derived mesenchymal stromal cells: a promising therapeutic potential with anti-inflammatory and pro-angiogenic profiles. Stem Cell Res Ther 10(1):322. https:\/\/doi.org\/10.1186\/s13287-019-1435-2","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"6634_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s13287-024-03963-2","volume":"15","author":"N Ebrahim","year":"2024","unstructured":"Ebrahim N, Kondratyev N, Artyuhov A et al (2024) Human pancreatic islet-derived stromal cells reveal combined features of mesenchymal stromal cells and pancreatic stellate cells. Stem Cell Res Ther 15(1):351. https:\/\/doi.org\/10.1186\/s13287-024-03963-2","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"6634_CR23","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/sctm.19-0023","volume":"8","author":"AA Arzouni","year":"2019","unstructured":"Arzouni AA, Vargas-Seymour A, Dhadda PK et al (2019) Characterization of the effects of mesenchymal stromal cells on mouse and human islet function. Stem Cells Transl Med 8(9):935\u2013944. https:\/\/doi.org\/10.1002\/sctm.19-0023","journal-title":"Stem Cells Transl Med"},{"issue":"3","key":"6634_CR24","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4161\/isl.2.3.11449","volume":"2","author":"F Carlotti","year":"2010","unstructured":"Carlotti F, Zaldumbide A, Loomans CJ et al (2010) Isolated human islets contain a distinct population of mesenchymal stem cells. Islets 2(3):164\u2013173. https:\/\/doi.org\/10.4161\/isl.2.3.11449","journal-title":"Islets"},{"issue":"11","key":"6634_CR25","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1038\/sj.cdd.4402199","volume":"14","author":"R Gallo","year":"2007","unstructured":"Gallo R, Gambelli F, Gava B et al (2007) Generation and expansion of multipotent mesenchymal progenitor cells from cultured human pancreatic islets. Cell Death Differ 14(11):1860\u20131871. https:\/\/doi.org\/10.1038\/sj.cdd.4402199","journal-title":"Cell Death Differ"},{"issue":"12","key":"6634_CR26","doi-asserted-by":"publisher","first-page":"e28175","DOI":"10.1371\/journal.pone.0028175","volume":"6","author":"C Zanini","year":"2011","unstructured":"Zanini C, Bruno S, Mandili G et al (2011) Differentiation of mesenchymal stem cells derived from pancreatic islets and bone marrow into islet-like cell phenotype. PLoS One 6(12):e28175. https:\/\/doi.org\/10.1371\/journal.pone.0028175","journal-title":"PLoS One"},{"issue":"4","key":"6634_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315\u2013317. https:\/\/doi.org\/10.1080\/14653240600855905","journal-title":"Cytotherapy"},{"issue":"10","key":"6634_CR28","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.jcyt.2019.08.002","volume":"21","author":"S Viswanathan","year":"2019","unstructured":"Viswanathan S, Shi Y, Galipeau J et al (2019) Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT(R)) Mesenchymal Stromal Cell committee position statement on nomenclature. Cytotherapy 21(10):1019\u20131024. https:\/\/doi.org\/10.1016\/j.jcyt.2019.08.002","journal-title":"Cytotherapy"},{"issue":"6","key":"6634_CR29","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1007\/s00125-020-05115-6","volume":"63","author":"P Leete","year":"2020","unstructured":"Leete P, Oram RA, McDonald TJ et al (2020) Studies of insulin and proinsulin in pancreas and serum support the existence of aetiopathological endotypes of type 1 diabetes associated with age at diagnosis. Diabetologia 63(6):1258\u20131267. https:\/\/doi.org\/10.1007\/s00125-020-05115-6","journal-title":"Diabetologia"},{"issue":"5","key":"6634_CR30","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.2337\/db15-1615","volume":"65","author":"P Leete","year":"2016","unstructured":"Leete P, Willcox A, Krogvold L et al (2016) Differential insulitic profiles determine the extent of \u03b2-cell destruction and the age at onset of type 1 diabetes. Diabetes 65(5):1362\u20131369. https:\/\/doi.org\/10.2337\/db15-1615","journal-title":"Diabetes"},{"issue":"9","key":"6634_CR31","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41574-023-00853-0","volume":"19","author":"MJ Redondo","year":"2023","unstructured":"Redondo MJ, Morgan NG (2023) Heterogeneity and endotypes in type 1 diabetes mellitus. Nat Rev Endocrinol 19(9):542\u2013554. https:\/\/doi.org\/10.1038\/s41574-023-00853-0","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"6634_CR32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4161\/isl.19256","volume":"4","author":"G Kilimnik","year":"2012","unstructured":"Kilimnik G, Jo J, Periwal V, Zielinski MC, Hara M (2012) Quantification of islet size and architecture. Islets 4(2):167\u2013172. https:\/\/doi.org\/10.4161\/isl.19256","journal-title":"Islets"},{"issue":"1","key":"6634_CR33","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fernandez JA et al (2017) QuPath: open source software for digital pathology image analysis. Sci Rep 7(1):16878. https:\/\/doi.org\/10.1038\/s41598-017-17204-5","journal-title":"Sci Rep"},{"key":"6634_CR34","unstructured":"R Core Team (2024) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria"},{"issue":"46","key":"6634_CR35","doi-asserted-by":"publisher","first-page":"eadz2251","DOI":"10.1126\/sciadv.adz2251","volume":"11","author":"K Murrall","year":"2025","unstructured":"Murrall K, Luckett T, Lekka C et al (2025) Small things matter: lack of extraislet \u03b2 cells in type 1 diabetes. Sci Adv 11(46):eadz2251. https:\/\/doi.org\/10.1126\/sciadv.adz2251","journal-title":"Sci Adv"},{"issue":"1","key":"6634_CR36","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1038\/s41467-024-47686-7","volume":"15","author":"J Lehrstrand","year":"2024","unstructured":"Lehrstrand J, Davies WIL, Hahn M, Korsgren O, Alanentalo T, Ahlgren U (2024) Illuminating the complete \u03b2-cell mass of the human pancreas- signifying a new view on the islets of Langerhans. Nat Commun 15(1):3318. https:\/\/doi.org\/10.1038\/s41467-024-47686-7","journal-title":"Nat Commun"},{"issue":"3","key":"6634_CR37","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.cmet.2018.11.014","volume":"29","author":"N Damond","year":"2019","unstructured":"Damond N, Engler S, Zanotelli VRT et al (2019) A map of human type 1 diabetes progression by imaging mass cytometry. Cell Metab 29(3):755-768 e755. https:\/\/doi.org\/10.1016\/j.cmet.2018.11.014","journal-title":"Cell Metab"},{"issue":"2","key":"6634_CR38","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1365-2249.2008.03860.x","volume":"155","author":"A Willcox","year":"2009","unstructured":"Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG (2009) Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 155(2):173\u2013181. https:\/\/doi.org\/10.1111\/j.1365-2249.2008.03860.x","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"6634_CR39","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s00125-012-2763-2","volume":"56","author":"CP Wheeler-Jones","year":"2013","unstructured":"Wheeler-Jones CP, Clarkin CE, Farrar CE et al (2013) Endoglin (CD105) is not a specific selection marker for endothelial cells in human islets of Langerhans. Diabetologia 56(1):222\u2013224. https:\/\/doi.org\/10.1007\/s00125-012-2763-2","journal-title":"Diabetologia"},{"issue":"2","key":"6634_CR40","first-page":"126","volume":"88","author":"W Vogel","year":"2003","unstructured":"Vogel W, Gr\u00fcnebach F, Messam CA, Kanz L, Brugger W, B\u00fchring HJ (2003) Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cells. Haematologica 88(2):126\u2013133","journal-title":"Haematologica"},{"issue":"2","key":"6634_CR41","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/stem.780","volume":"30","author":"D Grcevic","year":"2012","unstructured":"Grcevic D, Pejda S, Matthews BG et al (2012) In vivo fate mapping identifies mesenchymal progenitor cells. Stem Cells 30(2):187\u2013196. https:\/\/doi.org\/10.1002\/stem.780","journal-title":"Stem Cells"},{"issue":"6","key":"6634_CR42","doi-asserted-by":"publisher","first-page":"e15279","DOI":"10.1111\/dme.15279","volume":"41","author":"W Xu","year":"2024","unstructured":"Xu W, Zhou Y, Wang T et al (2024) Mouse islet-derived stellate cells are similar to, but distinct from, mesenchymal stromal cells and influence the beta cell function. Diabet Med 41(6):e15279. https:\/\/doi.org\/10.1111\/dme.15279","journal-title":"Diabet Med"},{"issue":"1","key":"6634_CR43","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.yexcr.2015.11.002","volume":"341","author":"M Zha","year":"2016","unstructured":"Zha M, Xu W, Jones PM, Sun Z (2016) Isolation and characterization of human islet stellate cells. Exp Cell Res 341(1):61\u201366. https:\/\/doi.org\/10.1016\/j.yexcr.2015.11.002","journal-title":"Exp Cell Res"},{"issue":"2","key":"6634_CR44","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/labinvest.3700377","volume":"86","author":"KL Seeberger","year":"2006","unstructured":"Seeberger KL, Dufour JM, Shapiro AM, Lakey JR, Rajotte RV, Korbutt GS (2006) Expansion of mesenchymal stem cells from human pancreatic ductal epithelium. Lab Invest 86(2):141\u2013153. https:\/\/doi.org\/10.1038\/labinvest.3700377","journal-title":"Lab Invest"},{"key":"6634_CR45","doi-asserted-by":"publisher","first-page":"2142646","DOI":"10.1155\/2016\/2142646","volume":"2016","author":"S Lee","year":"2016","unstructured":"Lee S, Jeong S, Lee C, Oh J, Kim SC (2016) Mesenchymal stem cells derived from human exocrine pancreas spontaneously express pancreas progenitor-cell markers in a cell-passage-dependent manner. Stem Cells Int 2016:2142646. https:\/\/doi.org\/10.1155\/2016\/2142646","journal-title":"Stem Cells Int"},{"issue":"1","key":"6634_CR46","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13287-020-01649-z","volume":"11","author":"O Villard","year":"2020","unstructured":"Villard O, Armanet M, Couderc G et al (2020) Characterization of immortalized human islet stromal cells reveals a MSC-like profile with pancreatic features. Stem Cell Res Ther 11(1):158. https:\/\/doi.org\/10.1186\/s13287-020-01649-z","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"6634_CR47","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1634\/stemcells.2007-1122","volume":"26","author":"L da Silva Meirelles","year":"2008","unstructured":"da Silva Meirelles L, Caplan AI, Nardi NB (2008) In search of the in vivo identity of mesenchymal stem cells. Stem Cells 26(9):2287\u20132299. https:\/\/doi.org\/10.1634\/stemcells.2007-1122","journal-title":"Stem Cells"},{"issue":"1","key":"6634_CR48","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2337\/db06-0617","volume":"56","author":"SA Sarkar","year":"2007","unstructured":"Sarkar SA, Wong R, Hackl SI et al (2007) Induction of indoleamine 2,3-dioxygenase by interferon-\u03b3 in human islets. Diabetes 56(1):72\u201379. https:\/\/doi.org\/10.2337\/db06-0617","journal-title":"Diabetes"},{"issue":"8","key":"6634_CR49","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.2337\/db12-1256","volume":"62","author":"MJ Lima","year":"2013","unstructured":"Lima MJ, Muir KR, Docherty HM et al (2013) Suppression of epithelial-to-mesenchymal transitioning enhances ex vivo reprogramming of human exocrine pancreatic tissue toward functional insulin-producing \u03b2-like cells. Diabetes 62(8):2821\u20132833. https:\/\/doi.org\/10.2337\/db12-1256","journal-title":"Diabetes"},{"issue":"7","key":"6634_CR50","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1097\/MPA.0000000000000154","volume":"43","author":"E De Waele","year":"2014","unstructured":"De Waele E, Wauters E, Ling Z, Bouwens L (2014) Conversion of human pancreatic acinar cells toward a ductal-mesenchymal phenotype and the role of transforming growth factor \u03b2 and activin signaling. Pancreas 43(7):1083\u20131092. https:\/\/doi.org\/10.1097\/MPA.0000000000000154","journal-title":"Pancreas"},{"key":"6634_CR51","doi-asserted-by":"publisher","first-page":"130","DOI":"10.2741\/4380","volume":"21","author":"L da Silva Meirelles","year":"2016","unstructured":"da Silva Meirelles L, Bellagamba BC, Camassola M, Nardi NB (2016) Mesenchymal stem cells and their relationship to pericytes. Front Biosci (Landmark Ed) 21:130\u2013156. https:\/\/doi.org\/10.2741\/4380","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"8","key":"6634_CR52","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1007\/s00125-020-05168-7","volume":"63","author":"L Mateus Gon\u00e7alves","year":"2020","unstructured":"Mateus Gon\u00e7alves L, Pereira E, Werneck de Castro JP, Bernal-Mizrachi E, Alma\u00e7a J (2020) Islet pericytes convert into profibrotic myofibroblasts in a mouse model of islet vascular fibrosis. Diabetologia 63(8):1564\u20131575. https:\/\/doi.org\/10.1007\/s00125-020-05168-7","journal-title":"Diabetologia"},{"issue":"3","key":"6634_CR53","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.stem.2008.07.003","volume":"3","author":"M Crisan","year":"2008","unstructured":"Crisan M, Yap S, Casteilla L et al (2008) A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3(3):301\u2013313. https:\/\/doi.org\/10.1016\/j.stem.2008.07.003","journal-title":"Cell Stem Cell"},{"issue":"8","key":"6634_CR54","doi-asserted-by":"publisher","first-page":"112913","DOI":"10.1016\/j.celrep.2023.112913","volume":"42","author":"L Mateus Gon\u00e7alves","year":"2023","unstructured":"Mateus Gon\u00e7alves L, Fahd Qadir MM, Boulina M, Makhmutova M, Pereira E, Alma\u00e7a J (2023) Pericyte dysfunction and impaired vasomotion are hallmarks of islets during the pathogenesis of type 1 diabetes. Cell Rep 42(8):112913. https:\/\/doi.org\/10.1016\/j.celrep.2023.112913","journal-title":"Cell Rep"},{"issue":"7","key":"6634_CR55","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1164\/rccm.201306-1043OC","volume":"189","author":"ML Bustos","year":"2014","unstructured":"Bustos ML, Huleihel L, Kapetanaki MG et al (2014) Aging mesenchymal stem cells fail to protect because of impaired migration and antiinflammatory response. Am J Respir Crit Care Med 189(7):787\u2013798. https:\/\/doi.org\/10.1164\/rccm.201306-1043OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"6634_CR56","doi-asserted-by":"publisher","first-page":"E234","DOI":"10.1210\/jc.2010-0932","volume":"95","author":"S Perl","year":"2010","unstructured":"Perl S, Kushner JA, Buchholz BA et al (2010) Significant human \u03b2-cell turnover is limited to the first three decades of life as determined by in vivo thymidine analog incorporation and radiocarbon dating. J Clin Endocrinol Metab 95(10):E234\u2013E239. https:\/\/doi.org\/10.1210\/jc.2010-0932","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"6634_CR57","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00125-015-3752-z","volume":"59","author":"ML Campbell-Thompson","year":"2016","unstructured":"Campbell-Thompson ML, Kaddis JS, Wasserfall C et al (2016) The influence of type 1 diabetes on pancreatic weight. Diabetologia 59(1):217\u2013221. https:\/\/doi.org\/10.1007\/s00125-015-3752-z","journal-title":"Diabetologia"},{"issue":"40","key":"6634_CR58","doi-asserted-by":"publisher","first-page":"eabo3932","DOI":"10.1126\/sciadv.abo3932","volume":"8","author":"S Shrestha","year":"2022","unstructured":"Shrestha S, Erikson G, Lyon J et al (2022) Aging compromises human islet beta cell function and identity by decreasing transcription factor activity and inducing ER stress. Sci Adv 8(40):eabo3932. https:\/\/doi.org\/10.1126\/sciadv.abo3932","journal-title":"Sci Adv"},{"issue":"23","key":"6634_CR59","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1042\/CS20171251","volume":"131","author":"AA Arzouni","year":"2017","unstructured":"Arzouni AA, Vargas-Seymour A, Rackham CL et al (2017) Mesenchymal stromal cells improve human islet function through released products and extracellular matrix. Clin Sci (Lond) 131(23):2835\u20132845. https:\/\/doi.org\/10.1042\/CS20171251","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"6634_CR60","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2337\/db15-0990","volume":"65","author":"CL Rackham","year":"2016","unstructured":"Rackham CL, Vargas AE, Hawkes RG et al (2016) Annexin A1 is a key modulator of mesenchymal stromal cell-mediated improvements in islet function. Diabetes 65(1):129\u2013139. https:\/\/doi.org\/10.2337\/db15-0990","journal-title":"Diabetes"},{"issue":"12","key":"6634_CR61","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.jcyt.2018.07.007","volume":"20","author":"CL Rackham","year":"2018","unstructured":"Rackham CL, Amisten S, Persaud SJ, King AJF, Jones PM (2018) Mesenchymal stromal cell secretory factors induce sustained improvements in islet function pre- and post-transplantation. Cytotherapy 20(12):1427\u20131436. https:\/\/doi.org\/10.1016\/j.jcyt.2018.07.007","journal-title":"Cytotherapy"},{"issue":"4","key":"6634_CR62","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/stem.3134","volume":"38","author":"CL Rackham","year":"2020","unstructured":"Rackham CL, Hubber EL, Czajka A, Malik AN, King AJF, Jones PM (2020) Optimizing beta cell function through mesenchymal stromal cell-mediated mitochondria transfer. Stem Cells 38(4):574\u2013584. https:\/\/doi.org\/10.1002\/stem.3134","journal-title":"Stem Cells"},{"issue":"5","key":"6634_CR63","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/TP.0b013e3181c7dc99","volume":"89","author":"KS Park","year":"2010","unstructured":"Park KS, Kim YS, Kim JH et al (2010) Trophic molecules derived from human mesenchymal stem cells enhance survival, function, and angiogenesis of isolated islets after transplantation. Transplantation 89(5):509\u2013517. https:\/\/doi.org\/10.1097\/TP.0b013e3181c7dc99","journal-title":"Transplantation"},{"issue":"11","key":"6634_CR64","doi-asserted-by":"publisher","first-page":"e0206449","DOI":"10.1371\/journal.pone.0206449","volume":"13","author":"A Gamble","year":"2018","unstructured":"Gamble A, Pawlick R, Pepper AR et al (2018) Improved islet recovery and efficacy through co-culture and co-transplantation of islets with human adipose-derived mesenchymal stem cells. PLoS One 13(11):e0206449. https:\/\/doi.org\/10.1371\/journal.pone.0206449","journal-title":"PLoS One"},{"issue":"1","key":"6634_CR65","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/MOT.0b013e32835c2adf","volume":"18","author":"JL Reading","year":"2013","unstructured":"Reading JL, Sabbah S, Busch S, Tree TI (2013) Mesenchymal stromal cells as a means of controlling pathological T-cell responses in allogeneic islet transplantation. Curr Opin Organ Transplant 18(1):59\u201364. https:\/\/doi.org\/10.1097\/MOT.0b013e32835c2adf","journal-title":"Curr Opin Organ Transplant"},{"key":"6634_CR66","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3389\/fimmu.2018.00645","volume":"9","author":"F Carty","year":"2018","unstructured":"Carty F, Corbett JM, Cunha JPMC et al (2018) Multipotent adult progenitor cells suppress T cell activation in in vivo models of homeostatic proliferation in a prostaglandin E2-dependent manner. Front Immunol 9:645. https:\/\/doi.org\/10.3389\/fimmu.2018.00645","journal-title":"Front Immunol"},{"issue":"526","key":"6634_CR67","doi-asserted-by":"publisher","first-page":"eaan5907","DOI":"10.1126\/scitranslmed.aan5907","volume":"12","author":"S Forbes","year":"2020","unstructured":"Forbes S, Bond AR, Thirlwell KL et al (2020) Human umbilical cord perivascular cells improve human pancreatic islet transplant function by increasing vascularization. Sci Transl Med 12(526):eaan5907. https:\/\/doi.org\/10.1126\/scitranslmed.aan5907","journal-title":"Sci Transl Med"},{"issue":"10","key":"6634_CR68","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.2337\/db10-0136","volume":"59","author":"DM Berman","year":"2010","unstructured":"Berman DM, Willman MA, Han D et al (2010) Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates. Diabetes 59(10):2558\u20132568. https:\/\/doi.org\/10.2337\/db10-0136","journal-title":"Diabetes"},{"issue":"11","key":"6634_CR69","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1089\/scd.2011.0634","volume":"21","author":"GI Bell","year":"2012","unstructured":"Bell GI, Meschino MT, Hughes-Large JM, Broughton HC, Xenocostas A, Hess DA (2012) Combinatorial human progenitor cell transplantation optimizes islet regeneration through secretion of paracrine factors. Stem Cells Dev 21(11):1863\u20131876. https:\/\/doi.org\/10.1089\/scd.2011.0634","journal-title":"Stem Cells Dev"},{"issue":"12","key":"6634_CR70","doi-asserted-by":"publisher","first-page":"e15227","DOI":"10.1111\/dme.15227","volume":"40","author":"TW Hong","year":"2023","unstructured":"Hong TW, Caxaria S, Daniels Gatward LF et al (2023) Mesenchymal stromal cell secretory molecules improve the functional survival of human islets. Diabet Med 40(12):e15227. https:\/\/doi.org\/10.1111\/dme.15227","journal-title":"Diabet Med"},{"issue":"2","key":"6634_CR71","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/bjp.2008.252","volume":"155","author":"F D'Acquisto","year":"2008","unstructured":"D\u2019Acquisto F, Perretti M, Flower RJ (2008) Annexin-A1: a pivotal regulator of the innate and adaptive immune systems. Br J Pharmacol 155(2):152\u2013169. https:\/\/doi.org\/10.1038\/bjp.2008.252","journal-title":"Br J Pharmacol"},{"key":"6634_CR72","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1146\/annurev-pharmtox-051821-042743","volume":"63","author":"M Perretti","year":"2023","unstructured":"Perretti M, Dalli J (2023) Resolution pharmacology: focus on pro-resolving annexin A1 and lipid mediators for therapeutic innovation in inflammation. Annu Rev Pharmacol Toxicol 63:449\u2013469. https:\/\/doi.org\/10.1146\/annurev-pharmtox-051821-042743","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"12","key":"6634_CR73","doi-asserted-by":"publisher","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","volume":"103","author":"R Meisel","year":"2004","unstructured":"Meisel R, Zibert A, Laryea M, G\u00f6bel U, D\u00e4ubener W, Dilloo D (2004) Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103(12):4619\u20134621. https:\/\/doi.org\/10.1182\/blood-2003-11-3909","journal-title":"Blood"},{"issue":"8","key":"6634_CR74","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1002\/stem.118","volume":"27","author":"G Ren","year":"2009","unstructured":"Ren G, Su J, Zhang L et al (2009) Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells 27(8):1954\u20131962. https:\/\/doi.org\/10.1002\/stem.118","journal-title":"Stem Cells"},{"issue":"7","key":"6634_CR75","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11892-015-0616-3","volume":"15","author":"PO Carlsson","year":"2015","unstructured":"Carlsson PO, Korsgren O, Le Blanc K (2015) Mesenchymal stromal cells to halt the progression of type 1 diabetes? Curr Diab Rep 15(7):46. https:\/\/doi.org\/10.1007\/s11892-015-0616-3","journal-title":"Curr Diab Rep"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06634-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-025-06634-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-025-06634-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T15:52:00Z","timestamp":1772553120000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-025-06634-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,21]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["6634"],"URL":"https:\/\/doi.org\/10.1007\/s00125-025-06634-w","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,21]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors would like to thank K. Murrall (University of Exeter) for providing calculations for the determination of islet bin sizes within this manuscript. This research was performed with the support of the Network for Pancreatic Organ Donors with Diabetes (nPOD; RRID:SCR_014641), a collaborative type 1 diabetes research project supported by Breakthrough T1D and The Leona M. & Harry B. Helmsley Charitable Trust (grant 3-SRA-2023-1417-S-B). The content and views expressed are the responsibility of the authors and do not necessarily reflect the official view of nPOD. Organ Procurement Organizations (OPOs) partnering with nPOD to provide research resources are listed at\n                      \n                      . The authors gratefully acknowledge the Exeter Centre for Cytomics at the University of Exeter for their support and assistance with this work. This study has been delivered through the National Institute for Health and Care Research (NIHR) Exeter Biomedical Research Centre (BRC). The views expressed are those of the authors and do not necessarily reflect those of Breakthrough T1D, Diabetes UK, the NIHR or the Department of Health and Social Care.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Acknowledgements"}},{"value":"All data are available in the main text or the electronic supplementary material (\n                      \n                      ) or are available from the corresponding authors upon reasonable request. For the purpose of open access, the author has applied a Creative Commons Attribution (CC BY) licence to any Author Accepted Manuscript version arising from this submission.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"This research was funded by a Breakthrough T1D International Strategic Research Agreement Grant (3-SRA-2023-1311-S-B, CR\/SR\/NGM), Breakthrough T1D UK Small Grant Award (1-SGA-2024-0003, RD-T\/CR), Diabetes UK (21\/0006353, CR\/NGM) and Research England\u2019s Expanding Excellence in England (E3) fund via EXCEED (CR). RD-T is funded by Breakthrough T1D (3-SRA-2023-1311-S-B). JA is funded by a Diabetes UK PhD studentship (21\/0006353). SR is supported by a Steve Morgan Foundation Grand Challenge Senior Research Fellowship (22\/0006504). The study sponsors\/funders were not involved in the design of the study; the collection, analysis, and interpretation of data; writing the report; and did not impose any restrictions regarding the publication of the report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors' relationships and activities"}},{"value":"RD-T was involved in the conception and design; financial support; acquisition, analysis and interpretation of data; and drafting and critical review of the manuscript. JA was involved in the acquisition of data and critical review of the manuscript. NM was involved in the conception and design, financial support, interpretation of data and critical review of the manuscript. ME was involved in the conception and design, analysis and interpretation of data and critical review of the manuscript. SR was involved in the conception and design, financial support, interpretation of data and critical review of the manuscript. CR was involved in the conception and design, financial support, interpretation of data and drafting and critical review of the manuscript. All authors approved the final version of the manuscript. CR was the principal investigator supervising this study and is the guarantor for this work.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}}]}}